You are here

Home

Clinical Trials: Bone Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: 02/18/2021 - 12:00
Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD
Conditions:   Intervertebral Disc Degeneration;   Chronic Low-back Pain
Interventions:   Drug: Autologous BM-MSC;   Other: Sham Procedure
Sponsors:   Campus Bio-Medico University;   Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico;   Center for Outcomes Research and Clinical Epidemiology, Italy
Recruiting
Posted: 02/03/2021 - 12:00
Randomized Study of Stem Cells vs. Steroids for Discogenic Back Pain
Conditions:   Chronic Low Back Pain;   Degenerative Disc Disease
Interventions:   Other: Autologous stem cells;   Drug: Corticosteroid;   Drug: Local anesthetic
Sponsors:   Johns Hopkins University;   The Geneva Foundation;   United States Department of Defense
Not yet recruiting
Posted: 09/03/2020 - 12:00
The SAFE Trial. Sterile Amniotic Fluid Filtrate Epidural Injection.
Condition:   Lumbar Spinal Stenosis
Interventions:   Drug: Amniotic Fluid Allograft;   Drug: Dexamethasone sodium phosphate
Sponsors:   University of Utah;   Cell Therapy & Regenerative Medicine;   SKAGGs Foundation
Not yet recruiting
Posted: 08/06/2020 - 12:00
Evaluation of Clinical and Bone Density Improvement After Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord on Osteoporosis Patients
Condition:   Osteoporosis
Intervention:   Drug: Mesenchymal Stem Cell
Sponsor:   Ahmad Jabir Rahyussalim
Recruiting
Posted: 08/05/2020 - 12:00
Effectiveness and Safety of Mesenchymal Stem Cell (MSC) Implantation on Degenerative Discus Disease Patients
Conditions:   Degenerative Disc Disease;   Low Back Pain;   Disc Degeneration
Intervention:   Drug: Mesenchymal Stem Cell + NaCl 0,9% 2ml
Sponsor:   Ahmad Jabir Rahyussalim
Recruiting
Posted: 07/30/2020 - 12:00
Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection
Conditions:   Spinal Tuberculosis;   Mesenchymal Stem Cell
Interventions:   Combination Product: Mesenchymal Stem cell + Nacl 0.9%;   Combination Product: NaCl 0.9%
Sponsor:   Ahmad Jabir Rahyussalim
Recruiting
Posted: 06/03/2020 - 12:00
Human Umbilical Cord Mesenchymal Stem Cells For the Treatment of Lumbar Disc Degeneration Disease
Conditions:   Lumbar Disc Degeneration;   Lumbar Disc Herniation
Intervention:   Other: human umbilical cord mesenchymal stem cells
Sponsor:   Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Recruiting
Posted: 03/06/2020 - 12:00
Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting
Condition:   Alveolar Bone Atrophy
Interventions:   Combination Product: Advanced medicinal Therapy (MSC combined with biomaterial);   Procedure: Autologous bone graft
Sponsors:   University of Bergen;   Université de Nantes;   University of Ulm;   Universidad Complutense de Madrid;   University of Aarhus;   Universitat Internacional de Catalunya;   Assistance Publique - Hôpitaux de Paris;   European Commission
Recruiting
Posted: 08/02/2019 - 12:00
A Phase 2, DB, Randomized Study of a Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
Condition:   Chronic Lumbar Disc Disease (cLDD)
Intervention:   Biological: BRTX-100
Sponsor:   BioRestorative Therapies
Not yet recruiting
Posted: 05/20/2019 - 12:00
Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Disc Degeneration
Condition:   Degenerative Disc Disease
Interventions:   Biological: IDCT;   Procedure: Sham
Sponsor:   DiscGenics, Inc.
Not yet recruiting

Pages